20291 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Sub-classes:THERAPEUTIC DRUG COMBINATIONS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#2METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS
#3LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#4TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#5HETEROCYCLIC COMPOUND AS TAAR1 LIGAND AGONIST
#6CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#7SMALL MOLECULE ANTAGONISTS OF PF4
#8LIQUID-DISPERSIBLE HALOPYRUVATE FORMULATIONS AND ASSOCIATED METHODS
#9COMPOSITIONS COMPRISING A NON-BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR
#10COMBINATORIAL, AND ROTATIONAL COMBINATORIAL THERAPIES
#11METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE
#12ORALLY SAFE BINDING SYSTEMS FOR TREATING DISEASE
#13ASSOCIATION WITH ANTIBIOTIC ACTIVITY, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND THEIR USE IN THE TREATMENT OF INFECTIONS
#14COMBINATION, COMPOSITION, AND METHOD OF ADMINISTERING THE COMBINATION OR COMPOSITION TO ANIMALS
#15METHOD OF ADMINISTRATION OF BRYOSTATIN FOR THE INDUCTION OF TUMOR ASSOCIATED ANTIGENS
#16Compound, Pharmaceutical Composition Comprising the Same and Method for Treating Cancer Using the Same
#17SYNBIOTIC SUPPLEMENT FORMULATION
#18PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#19BIOORTHOGONAL COMPOSITIONS
#20METHODS AND COMPOSITIONS FOR TREATING MELANOMA
#21VACCINE PREPARATION
#22NITROGEN-CONTAINING DERIVATIVES OF SALINOMYCIN, SYNTHESIS AND USES THEREOF
#23EFFECTIVE EYELID, FACE, HEAD AND BODY CLEANSER
#24METHODS AND COMPOSITIONS FOR PERTURBING MONOCYTE AND NEUTROPHIL LINEAGES
#25Methods For Administering Weight Loss Medications
#26METHODS FOR THE TREATMENT OF DIABETIC RETINOPATHY AND OTHER OPHTHALMIC DISEASES
#27IMMUNOMODULATION FOR THE LONG TERM PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES AND FOREIGN TISSUE REJECTION
#28Sesquiterpenoid derivative and use thereof in preparing broad-spectrum antiviral drug
#29Methods For and Products From Encapsulation of Drugs in Nanoparticles in a Microgravity Environment
#30MODULATORS OF THE INTEGRATED STRESS PATHWAY
#31USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#32TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#33SYSTEMS AND METHODS FOR TREATING AND INHIBITING WOUND INFECTIONS
#34METHODS FOR IDENTIFYING COMPOSITIONS FOR INHIBITING VIRAL INFECTIVITY
#35CONJUGATE AND USE THEREOF
#36NANOPARTICLES AND METHODS OF MANUFACTURE THEREOF
#37SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS
#38Use of cannabinoids in the treatment of epilepsy
#39Layered Pharmaceutical Formulations
#40NITROGEN-CONTAINING ANALOGS OF SALINOMYCIN FOR USE IN ACUTE MYELOID LEUKEMIA
#41ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#42COMPOSITION AND METHOD FOR TREATING CANCER
#43LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#44IRON-SCORE AND IN VITRO METHOD FOR IDENTIFYING HIGH RISK DLBCL SUBJECTS AND THERAPEUTIC USES AND METHODS
#45MEAYAMYCIN AND ITS ANALOGUES, METHODS FOR THEIR PREPARATION, AND METHODS OF USE
#46TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS
#47Genetic polymorphisms associated with stroke, methods of detection and uses thereof
#48TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS
#49ENHANCED ANTIVIRULENT FOR ANTIBIOTIC-RESISTANT BACTERIA
#50COMPOSITION OF TANNIC ACID AND VITAMIN D AND METHODS OF USE
#51NOVEL AND POTENT JAK/STAT INHIBITOR
#52KIT, COMPOSITION, AND COMBINATION THERAPY FOR FRAGILE X SYNDROME
#53METHODS OF TREATING CANCER
#54DEVICE FOR INTERNAL AND EXTERNAL NASAL APPLICATION
#55SKIN-CARE BALM AND DEVICE FOR INTERNAL AND EXTERNAL NASAL APPLICATION
#56Use of cannabinoids in the treatment of epilepsy
#57USE OF COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT, DIMER OR TRIMER THEREOF IN MANUFACTURE OF MEDICAMENT FOR TREATING CANCER
#58METHODS FOR AND PRODUCTS FROM ENCAPSULATION OF DRUGS IN NANOPARTICLES IN A MICROGRAVITY ENVIRONMENT
#59ANTIVIRAL EFFECTS OF NARASIN IN SWINE FEED
#60Endoparasitic depsipeptides
#61CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#62Opioid receptor ligands and methods of using and making same
#63Biguanide compositions and methods of treating metabolic disorders
#64Soft Chewable Pharmaceutical Products
#65DISSOLVABLE MICRO-INGREDIENT CONTAINERS AND METHODS FOR PREPARING ANIMAL FEEDS USING SUCH CONTAINERS
#66BIOORTHOGONAL COMPOSITIONS
#67PROCESS FOR REMOVING IONS FROM BODILY FLUIDS USING SMALL MOLECULE METAL CHELATORS AND METALLATE ION EXCHANGE COMPOSITIONS
#68Compounds derived from and uses thereof
#69PEROXIDE-LESS BIOPHOTONIC COMPOSITIONS AND METHODS
#70Composition for preventing or treating cellular senescence-related diseases comprising salinomycin as effective component
#71Use of cannabinoids in the treatment of epilepsy
#72Anti-cancer agents and preparation thereof
#73MODULATORS OF THE INTEGRATED STRESS PATHWAY
#74ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#75LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#76Compositions and Methods for Increasing Insulin Sensitivity
#77THERAPEUTIC COMPOSITIONS, PRODUCTS OF MANUFACTURE AND METHODS FOR AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#78COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE, OR MINERAL
#79METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS
#80Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#81THERAPEUTIC COMPOSITIONS, PRODUCTS OF MANUFACTURE AND METHODS FOR AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#82COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE, OR MINERAL
#83COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE OR MINERAL
#84Anti-dandruff composition
#85Dissolvable micro-ingredient containers and methods for preparing animal feeds using such containers
#86PROCESS FOR PRODUCING AN EXTRACT CONTAINING TETRAHYDROCANNABINOL AND CANNABIDIOL FROM CANNABIS PLANT MATERIAL, AND CANNABIS EXTRACTS
#87Solid oral pharmaceutical compositions for isoxazoline compounds
#88Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
#89METHOD OF IMPROVING MUSCLE AND CONNECTIVE TISSUE WITH SHILAJIT
#90TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#91NOVEL COMBINATION PRODUCT
#92Combination, composition, and method of administering the combination or composition to animals
#93PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES
#94Use of cannabinoids in the treatment of epilepsy
#95DEVICE AND METHOD FOR ADMINISTERING AN ACTIVE INGREDIENT
#96Cofilin phosphorylation for quantifying CD4 T cell damage and predict CD4 T cell recovery from anti-retroviral therapy
#97ANTI-INFECTIVE ANTIMICROBIAL-CONTAINING BIOMATERIALS
#98PRINTABLE CANNABINOID AND TERPENE COMPOSITIONS
#99Methods of Treating Hyperalgesia
#100TOPICAL COMPOSITIONS
#101PROCESS FOR PRODUCING AN EXTRACT CONTAINING TETRAHYDROCANNABINOL AND CANNABIDIOL FROM CANNABIS PLANT MATERIAL, AND CANNABIS EXTRACTS
#102PREVENTION OR TREATMENT OF CHRONIC ORGAN INJURY
#103Topical formulations with resiniferatoxin nanoparticles and methods
#104Genetic polymorphisms associated with stroke, methods of detection and uses thereof
#105USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#106Methods for administering weight loss medications
#107Pharmaceutical composition for preventing and treating liver diseases, containing, as active ingredient, cromolyn or pharmaceutically acceptable salt thereof
#108Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity
#109SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE
#110Endoparasitic depsipeptides
#111PRESERVATION OF THE NEUROMUSCULAR JUNCTION AFTER TRAUMATIC NERVE INJURY
#112ENHANCED ANTIVIRULENT FOR ANTIBIOTIC-RESISTANT BACTERIA
#113METHODS OF MODULATING PROTEIN EXOCYTOSIS AND USES OF SAME IN THERAPY
#114Method of Treatment of Cancer
#115Treatment of metabolic disorders in feline animals
#116ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#117LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#118USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#119COMPOSITION AND METHOD OF CONTROLLING INFECTIOUS DISEASES WITH FUNCTIONAL FRAGRANCES
#120Cromolyn Compositions for Treatment of Chronic Cough Due to Idiopathic Pulmonary Fibrosis
#121Biguanide compositions and methods of treating metabolic disorders
#122COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#123TAU PHOSPHORYLATION INHIBITORS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE
#124Antimicrobial agents and their use in therapy
#125Cannabinoid and terpene-infused topical cream
#126PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#127TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#128Pharmaceutical preparation and method for its manufacture
#129Methods for treating B cell proliferative disorders
#130SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease
#131Derivatives of thailanstatin A, methods of treatment and methods of synthesis thereof
#132Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds
#133METHODS FOR THE TREATMENT OF MAST CELL RELATED DISORDERS WITH MAST CELL STABILIZERS
#134Combination, composition, and method of administering the combination or composition to animals
#135ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#136LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#137Opioid receptor ligands and methods of using and making same
#138Methods and systems for treating cell proliferation disorders
#139Cancer Treatment by Simultaneous Targeting Energy Metabolism and Intracellular pH
#140Kit, composition, and combination therapy for fragile X syndrome
#141Methods of treating skin with aromatic skin-active ingredients
#142Antiviral compositions for the treatment of infections linked to coronaviruses
#143Polymorphic forms and process
#144Method for Treating Obesity
#145Pharmaceutical composition of ivermectin and process for preparation thereof
#146Methods For Administering Weight Loss Medications
#147Method for Treating Obesity
#148Compositions And Methods For Increasing Insulin Sensitivity
#149Anti-cancer agents and preparation thereof
#150Inhibition of Zika Virus Infection
#151Compositions for affecting weight loss
#152METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS
#153Soft chewable pharmaceutical products
#154FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEREOF
#155Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
#156Methods for the treatment of mast cell related disorders with mast cell stabilizers
#157Methods for treating in dermatology and dermo-cosmetics by administering achene extract
#158Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
#159COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#160Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
#161SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease
#162METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS
#163Treatment of addiction and impulse-control disorders using PDE7 inhibitors
#164INHIBITION OF ADAPTOR ASSOCIATED KINASE 1 FOR THE TREATMENT OF PAIN
#165Polymorphic forms and process
#166Soft Chewable Pharmaceutical Product
#167Soft Chewable Pharmaceutical Products
#168THERAPEUTIC EFFECTS OF BRYOSTATINS, BRYOLOGS, AND OTHER RELATED SUBSTANCES ON HEAD TRAUMA-INDUCED MEMORY IMPAIRMENT AND BRAIN INJURY
#169Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors
#170Crosslinker enhanced repair of connective tissues
#171METHODS OF MODULATING PROTEIN EXOCYTOSIS AND USES OF SAME IN THERAPY
#172Printable cannabinoid and terpene compositions
#173Compositions and methods for prophylaxis and treatment of addictions
#174Peroxide-less biophotonic compositions and methods
#175Polymorphic forms and process
#176Compound for inhibiting binding between DX2 protein and p14/ARF protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient
#177Bioorthogonal compositions
#178Methods for administering weight loss medications
#179METHOD FOR CULTIVATION OF HYBRID MINT PLANT DESIGNATED 14-27-71 FOR PRODUCTION OF ESSENTIAL OIL COMPOSITION
#180METHOD FOR CULTIVATION OF HYBRID MINT PLANT DESIGNATED 14-41-16 FOR PRODUCTION OF ESSENTIAL OIL COMPOSITION
#181Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
#182Use of cannabinoids in the treatment of epilepsy
#183MODULATION OF AXON DEGENERATION
#184Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection
#185GENETIC POLYMORPHISMS ASSOCIATED WITH STROKE, METHODS OF DETECTION AND USES THEREOF
#186Aryl sulfonamides as BLT1 antagonists
#187Opioid receptor ligands and methods of using and making same
#188Immune tolerant and non-immune tolerant elastin-like recombinant peptides and methods of use
#189METHODS OF CANCER TREATMENT
#190PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES
#191Liposomal compositions with light illumination-induced drug release
#192Salinomycin derivatives and therapeutic uses thereof
#193Cross-linked star-shaped self-assembled polypeptides and its use as carriers in biomedical applications
#194Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
#195Methods for the treatment of mast cell related disorders with mast cell stabilizers
#196Pain-killing composition comprising a salicylic acid derivative
#197Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
#198Use of equol for treating androgen mediated diseases
#199Ligand ionophore conjugates
#200Monoterpenes for treating respiratory diseases, in particular bronchopulmonary diseases
#201Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#202Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods
#203Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
#204COMPOSITIONS AND METHODS FOR THE TREATMENT OF SLEEP APNEA
#205Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders
#206PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#207Use of Kaempferia parviflora wall. ex. baker extracts or flavone compound for preventing or treating muscle diseases, or improving muscle function
#208Composition for activating longevity genes, containing kojic acid derivative as active ingredient
#209TREATMENT METHOD FOR IMPROVING INTESTINAL ENVIORNMENT AND INTESTINAL TRACT BARRIER
#210Compositions Using Antibodies Directed to GPNMB and Uses Thereof
#211Antiviral compositions for treating the flu
#212Monensin water dispersible granules by wet granulation
#213USE OF ELLAGIC ACID DIHYDRATE IN PHARMACEUTICAL FORMULATIONS TO REGULATE BLOOD GLUCOSE LEVELS
#214Formulations of histone deacetylase inhibitor and uses thereof
#215Methods and compositions for attenuating allergenicity in protein products
#216Methods of treating hyperalgesia
#217Opioid receptor ligands and methods of using and making same
#218SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease
#219ANTIVIRAL EFFECTS OF NARASIN IN SWINE FEED
#220Soft chewable pharmaceutical products
#221Topical application of ivermectin for the treatment of dermatological conditions/afflictions
#222TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS
#223Hernia repair device and methods
#224Soft Chewable Pharmaceutical Products
#225COMPOSITIONS PURPOSEFULLY SELECTED COMPRISING PURIFIED CANNABINOIDS AND/OR PURIFIED TERPENES
#226Methods and systems for treating cell proliferation disorders
#227Nitrogen-containing analogs of salinomycin, synthesis and use against cancer stem cells and malaria
#228High-throughput screening for compounds modulating expression of cellular macromolecules
#229Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors
#230Biguanide compositions and methods of treating metabolic disorders
#231Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
#232Inhibitors of the PP1/GADD34 complex for the treatment of a condition requiring an immunosuppressive activity
#233Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders
#234USE OF A FEED COMPOSITION FOR REDUCING METHANE EMISSION IN RUMINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE
#235Furo[3,4-]pyran compounds and pharmaceutical uses
#236Combination, composition, and method of administering the combination or composition to animals
#237Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
#238Bipartite inhibitors of bacterial RNA polymerase
#239Compositions and methods for prophylaxis and treatment of addictions
#240METHODS AND COMPOSITIONS FOR THE TREATMENT OF VASCULAR MALFORMATION
#241Spliceostatin analogs and methods for their preparation
#242Cannabinoid receptor treatments
#243Compositions for treating retinal degeneration and methods of production and use thereof
#244Anti-microbial composition
#245Multitarget hedgehog pathway inhibitors and uses thereof
#246Tricyclic compounds and methods of making and using same
#247Treatment of respiratory disorders using ROR-gamma inhibitors
#248Endoxifen compositions and methods
#249Monoterpenes for treating respiratory disorders, in particular bronchopulmonary disorders
#250Methods for treating B cell proliferative disorders
#251Anti-cancer agents and preparation thereof
#252Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
#253Antimicrobial agents and their use in therapy
#254COMPOUND PARTICULARLY FOR TREATING DEPRESSION AND ANXIETY
#255Use of equol for treating androgen mediated diseases
#256COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE, OR MINERAL
#257Opioid receptor ligands and methods of using and making same
#258Method for cancer cell reprogramming
#259Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders
#260Extruded chewable formulation comprising bound water
#261Supression of IgE production by compounds derived from traditional chinese medicine
#262Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
#263ANTI-VIRAL COMPOSITIONS
#264Modulation of axon degeneration
#265Therapeutic Methods and Compositions
#266Pain relief compositions, manufacture and uses
#267Treatment of protein degradation disorders
#268Compositions and methods for treating psychiatric disorders
#269Methods of treating topical microbial infections
#270Methods of treating microbial infections, including mastitis
#271Composition and method for treating dry eye syndrome
#272Use of cannabinoids in the treatment of epilepsy
#273Use of cannabinoids in the treatment of epilepsy
#274Use of equol for treating androgen mediated diseases
#275Treatment of ADHD
#276BODY SURFACE TREATMENT COMPOSITION AND METHOD
#277Use of polyenylpyrrole derivatives for treating inflammation
#278Methods of treating patients infected with HIV and HTLV
#279Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof
#280Compounds useful for treating ocular neovasculan
#281Opioid receptor ligands and methods of using and making same
#282Modulators of hepatic lipoprotein metabolism
#283Methods relating to DNA-sensing pathway related conditions
#284Anticonvulsant combination therapy
#285Use of kaempferia parviflora wall. ex. baker extracts or flavone compound for preventing or treating muscle diseases, or improving muscle function
#286Method of making an anhydrous, fat soluble, chewable drug delivery formulation
#287Targeting a non-canonical notch signaling pathway for cancer treatment
#288Chemosensory receptor ligand-based therapies
#289Methods and compositions for treating cancer
#290Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity
#291Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
#292Small molecule modulators of the cold and menthol receptor TRPM8
#293Solid oral pharmaceutical compositions for isoxazoline compounds
#294Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
#295ENHANCED IMMEDIATE RELEASE FORMULATIONS OF TOPIRAMATE
#296Anti-infective antimicrobial-containing biomaterials
#297TOPICAL LOCALIZED ISOXAZOLINE FORMULATION COMPRISING GLYCOFUROL
#298Escalating dosing regimen for effecting weight loss and treating obesity
#299Low dose topiramate/phentermine composition and methods of use thereof
#300Collateral gene inactivation biomarkers and targets for cancer therapy